Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels

被引:125
作者
Zentilin, L
Taturo, S
Zacchigna, S
Arsic, N
Pattarini, L
Sinigaglia, M
Giacca, M
机构
[1] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34012 Trieste, Italy
[2] Univ Trieste, Fac Med, Trieste, Italy
关键词
D O I
10.1182/blood-2005-08-3215
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular endothelial growth factor (VEGF) is a key regulator of blood vessel formation during both vasculogenesis and angiogenesis. The prolonged expression of VEGF in the normoperfused skeletal muscles of adult rodents after gene transfer using AAV vectors induces the formation of a large set of new capillaries and small arteries. Notably, this process is accompanied by the massive Infiltration by mononuclear cells. This observation raises the possibility that these cells might represent circulating progenitors that are eventually incorporated in the newly formed vessels. Here we explore this possibility by exploiting 4 different experimental models based on (a) the transplantation of male bone marrow into female recipients; (b) the transplantation of Tie2-GFP transgenic bone marrow; (c) the transplantation of bone marrow in the presence of erythropoietin (EPO), a mobilizer of endothelial progenitor cells (EPCs); and (d) the reimplantation of ex vivo-expanded EPCs. In all 4 models, VEGF acted as a powerful attractor of bone marrow-derived mononuclear cells, bearing different myeloid and endothelial markers proper of the EPCs to the sites of neovascularization. In no case, however, were the attracted cells incorporated in the newly formed vasculature. These observations indicate that new blood vessel formation induced by VEGF occurs through bona fide sprouting angiogenesis; the contribution of the infiltrating bone marrow-derived cells to this process still remains enigmatic.
引用
收藏
页码:3546 / 3554
页数:9
相关论文
共 60 条
[41]   Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors [J].
Rehman, J ;
Li, JL ;
Orschell, CM ;
March, KL .
CIRCULATION, 2003, 107 (08) :1164-1169
[42]   The involvement of endothelial progenitor cells in tumor angiogenesis [J].
Ribatti, D .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2004, 8 (03) :294-300
[43]   Erythropoietin as an angiogenic factor [J].
Ribatti, D ;
Vacca, A ;
Roccaro, AM ;
Crivellato, E ;
Presta, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2003, 33 (10) :891-896
[44]   Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression [J].
Salcedo, R ;
Ponce, ML ;
Young, HA ;
Wasserman, K ;
Ward, JM ;
Kleinman, HK ;
Oppenheim, JJ ;
Murphy, WJ .
BLOOD, 2000, 96 (01) :34-40
[45]   SELECTIVE ATTRACTION OF MONOCYTES AND LYMPHOCYTES-T OF THE MEMORY PHENOTYPE BY CYTOKINE RANTES [J].
SCHALL, TJ ;
BACON, K ;
TOY, KJ ;
GOEDDEL, DV .
NATURE, 1990, 347 (6294) :669-671
[46]   Uniform vascular-endothelial-cell-specific gene expression in both embryonic and adult transgenic mice [J].
Schlaeger, TM ;
Bartunkova, S ;
Lawitts, JA ;
Teichmann, G ;
Risau, W ;
Deutsch, U ;
Sato, TN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :3058-3063
[47]   Diversity within pericytes [J].
Sims, DE .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2000, 27 (10) :842-846
[48]   Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle [J].
Springer, ML ;
Ozawa, CR ;
Banfi, A ;
Kraft, PE ;
Ip, TK ;
Brazelton, TR ;
Blau, HM .
MOLECULAR THERAPY, 2003, 7 (04) :441-449
[49]   Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization [J].
Takahashi, T ;
Kalka, C ;
Masuda, H ;
Chen, D ;
Silver, M ;
Kearney, M ;
Magner, M ;
Isner, JM ;
Asahara, T .
NATURE MEDICINE, 1999, 5 (04) :434-438
[50]   Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial [J].
Tateishi-Yuyama, E ;
Matsubara, H ;
Murohara, T ;
Ikeda, U ;
Shintani, S ;
Masaki, H ;
Amano, K ;
Kishimoto, Y ;
Yoshimoto, K ;
Akashi, H ;
Shimada, K ;
Iwasaka, T ;
Imaizumi, T .
LANCET, 2002, 360 (9331) :427-435